Ben Franklin Technology Partners
VC Fund
University Park, United States
Ben Franklin Technology Partners is a VC fund in University Park focused on Health Care and Software. Ben Franklin has provided the Capital, Knowledge and Networks that help innovative enterprises compete in the global marketplace, generating wealth and supporting regional economic growth. Ben Franklin has invested more than $165 million to grow more than 1,750 regional enterprises, across all areas of technology. It has launcheduniversity/industry partnerships that accelerate scientific discoveries to commercialization. The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.
- Total investments:
- 95
- Last investment:
- Lead investor:
- 49%
Last updated:
For AI agents: llms.txt
Industries Ben Franklin Technology Partners invests in
Stages Ben Franklin Technology Partners invests in
Countries Ben Franklin Technology Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $500k–$5.3M
- Grant
- $10k–$25k
- Series A
- $1.1M–$54M
Investment Focus
Industry
- Health Care 20 (21%)
- Software 17 (18%)
- Manufacturing 12 (13%)
- Information Technology 11 (12%)
- SaaS 8 (8%)
Stage
- Seed 34 (36%)
- Grant 25 (26%)
- Series A 10 (11%)
- Venture - Series Unknown 6 (6%)
- Pre-Seed 5 (5%)
Country
- United States 74 (78%)
- Kenya 1 (1%)
- Germany 1 (1%)
- Australia 1 (1%)
- United Kingdom 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Neil Kline
Executive In Residence
|
Executive In Residence | Total investments: 0 | Find email | |
Scott Nissenbaum
President and CEO
|
President and CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Meduloc provides a platform of solutions for small and long bone fractures using internal fixation. The company develops solutions to address the clinical needs of patients and surgeons. | $4M / Series B / Aug 06, 2026 | ||
| Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing. | $43M / Series A / May 04, 2026 | ||
| Moberg Analytics provides advanced analytics and AI for the management of patients in neurocritical care. They provide solutions for data aggregation, archiving, analysis, and visualization to promote precision care. They are developing a suite of analytic tools and AI Agents to provide a deeper insight into the injured brain. The Critical CareCopilot provides a generative AI interface between the clinician and the data. The company’s contact mode is via email. | $600K / Seed / Oct 22, 2025 | ||
| Kevo provides cold brew products made with regular grounds or K-cups. | $10K / Grant / Jan 24, 2025 | ||
| Developed a K-8 bully prevention program that takes a school-wide approach to reducing/eliminating aggressive behavior by promoting peer intervention. Schools are now mandated by law to offer programs such as Project TEAM, which includes materials, visuals, and software to not only the students but also the faculty. | $1.2M / Seed / Aug 06, 2024 | ||
| Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing. | $54M / Series A / May 02, 2024 | ||
| NovaData Solutions is an InsurTech company offering a platform for automated restoration invoice scraping, auditing, and analysis. The company's platform, called Rest-Assured, leverages advanced data strategies, OCR data capture, and AI learning to drive operational efficiencies, increase the effectiveness of financial anomaly detection, andaccelerate the audit process that enables customers to have automated invoice review, validation, and reconciliation. | Series A / Mar 20, 2024 | ||
| Zenapse is a internet publishing industry. | $8M / Seed / Mar 20, 2024 | ||
| PolicyMap is a data and online mapping tool for accessing data about communities. | $3M / Series A / Dec 19, 2023 | ||
| Finresi gives accredited investors access to passively invest in high yield, real estate secured loans, without the hassles of traditional real estate ownership. | $1.3M / Seed / Oct 16, 2023 | ||
| See all 95 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ben Franklin Technology Partners invest in?
Ben Franklin Technology Partners invests primarily in Health Care, Software and Manufacturing startups, most often at Seed and Grant stage. Most of the 95 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ben Franklin Technology Partners's check size?
Ben Franklin Technology Partners typically joins rounds of $500k–$5.3M at Seed, $10k–$25k at Grant and $1.1M–$54M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ben Franklin Technology Partners participates in.
How do I contact Ben Franklin Technology Partners?
Public channels for Ben Franklin Technology Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ben Franklin Technology Partners?
The team at Ben Franklin Technology Partners includes Neil Kline (Executive In Residence) and Scott Nissenbaum (President and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
